Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Nat Med. 2022 Jun 16;28(7):1412–1420. doi: 10.1038/s41591-022-01869-1

Table 2:

The performance metrics of the GPS in the testing cohorts meta-analyzed by ancestry. For performance testing in individual cohorts, please refer to Supplemental Tables 47.

Meta-analysis Case/control OR per SD (95% CI), P-value AUC (Crude) PRS Threshold Odds ratio (95% CI), P-value
European (3 cohorts) 14,201/82,849 1.46 (1.43-1.48), P<1.00E-300 0.81 (0.62) Top 20% vs. other 80% 2.30 (2.17-2.44), P=1.65E-174
Top 10% vs. other 90% 2.59 (2.40-2.78), P=1.27E-142
Top 5% vs. other 95% 2.92 (2.65-3.21), P=2.64E-104
Top 2% vs. other 98% 3.60 (3.11-4.17), P=4.26E-66
Top 1% vs. other 99% 4.46 (3.66-5.44), P=7.82E-50

African (6 cohorts) 4,268/10,276 1.32 (1.26-1.38), P=1.78E-33 0.78 (0.57) Top 20% vs. other 80% 1.65 (1.49-1.82), P=1.17E-22
Top 10% vs. other 90% 1.84 (1.61-2.09), P=9.26E-20
Top 5% vs. other 95% 2.06 (1.72-2.47), P=2.11E-15
Top 2% vs. other 98% 2.66 (2.01-3.51), P= 4.93E-12
Top 1% vs. other 99% 3.51 (2.37-5.22), P=4.21E-10

Latinx (2 cohorts) 1,386/2,239 1.42 (1.29-1.57), P=4.56E-12 0.88 (0.62) Top 20% vs. other 80% 1.88 (1.50-2.37), P=5.46E-08
Top 10% vs. other 90% 2.26 (1.66-3.06), P=1.56E-07
Top 5% vs. other 95% 2.67 (1.75-4.07), P=4.96E-06
Top 2% vs. other 98% 4.93 (2.46-9.89), P=6.69E-06
Top 1% vs. other 99% 6.61 (2.46-17.75), P=1.77E-04

Asian (4 cohorts) 392/8,233 1.68 (1.45-2.06), P=7.11E-13 0.91 (0.61) Top 20% vs. other 80% 2.42 (1.81-2.27), P=4.39E-09
Top 10% vs. other 90% 2.95 (2.06-4.20), P=2.43E-09
Top 5% vs. other 95% 3.56 (2.26-5.60), P=4.09E-08
Top 2% vs. other 98% 3.81 (1.91-7.59), P=1.35E-04
Top 1% vs. other 99% 8.46 (3.70-19.3), P=4.00E-07

All 15 cohorts 20,247/103,597 1.44 (1.42-1.47), P<1.00E-300 0.81 (0.61) Top 20% vs. other 80% 2.23 (2.11-2.35), P=8.02E-195
Top 10% vs. other 90% 2.31 (2.17-2.45), P=2.75E-168
Top 5% vs. other 95% 2.58 (2.39-2.79), P=2.02E-123
Top 2% vs. other 98% 3.26 (2.89-3.67), P=3.37E-84
Top 1% vs. other 99% 4.61 (3.84-5.53), P=1.14E-60

OR: Odds ratio for the model adjusted for age, sex, diabetes, principal components of ancestry and genotyping array or clinical site; SD: standard deviation of the GPS distribution in controls; AUC: area under the receiver-operator curve for the model adjusted for age, sex, diabetes, principal components of ancestry and genotyping array or clinical site (crude: AUC for GPS alone without any covariates).